Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

152 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Development of a standardized ELISA for the determination of autoantibodies against human M-type phospholipase A2 receptor in primary membranous nephropathy.
Dähnrich C, Komorowski L, Probst C, Seitz-Polski B, Esnault V, Wetzels JF, Hofstra JM, Hoxha E, Stahl RA, Lambeau G, Stöcker W, Schlumberger W. Dähnrich C, et al. Among authors: esnault v. Clin Chim Acta. 2013 Jun 5;421:213-8. doi: 10.1016/j.cca.2013.03.015. Epub 2013 Mar 27. Clin Chim Acta. 2013. PMID: 23541686
Prediction of membranous nephropathy recurrence after transplantation by monitoring of anti-PLA2R1 (M-type phospholipase A2 receptor) autoantibodies: a case series of 15 patients.
Seitz-Polski B, Payré C, Ambrosetti D, Albano L, Cassuto-Viguier E, Berguignat M, Jeribi A, Thouret MC, Bernard G, Benzaken S, Lambeau G, Esnault VL. Seitz-Polski B, et al. Nephrol Dial Transplant. 2014 Dec;29(12):2334-42. doi: 10.1093/ndt/gfu252. Epub 2014 Jul 25. Nephrol Dial Transplant. 2014. PMID: 25063424
Cross-reactivity of anti-PLA2R1 autoantibodies to rabbit and mouse PLA2R1 antigens and development of two novel ELISAs with different diagnostic performances in idiopathic membranous nephropathy.
Seitz-Polski B, Dolla G, Payré C, Tomas NM, Lochouarn M, Jeammet L, Mariat C, Krummel T, Burtey S, Courivaud C, Schlumberger W, Zorzi K, Benzaken S, Bernard G, Esnault VL, Lambeau G. Seitz-Polski B, et al. Biochimie. 2015 Nov;118:104-15. doi: 10.1016/j.biochi.2015.08.007. Epub 2015 Aug 19. Biochimie. 2015. PMID: 26296473
Epitope Spreading of Autoantibody Response to PLA2R Associates with Poor Prognosis in Membranous Nephropathy.
Seitz-Polski B, Dolla G, Payré C, Girard CA, Polidori J, Zorzi K, Birgy-Barelli E, Jullien P, Courivaud C, Krummel T, Benzaken S, Bernard G, Burtey S, Mariat C, Esnault VL, Lambeau G. Seitz-Polski B, et al. J Am Soc Nephrol. 2016 May;27(5):1517-33. doi: 10.1681/ASN.2014111061. Epub 2015 Nov 13. J Am Soc Nephrol. 2016. PMID: 26567246 Free PMC article.
[Membranous nephropathy: Pathophysiology and natural history].
Seitz-Polski B, Lambeau G, Esnault V. Seitz-Polski B, et al. Among authors: esnault v. Nephrol Ther. 2017 Apr;13 Suppl 1:S75-S81. doi: 10.1016/j.nephro.2017.01.012. Nephrol Ther. 2017. PMID: 28577747 Review. French.
Rituximab bioavailability in primary membranous nephropathy.
Boyer-Suavet S, Andreani M, Cremoni M, Brglez V, Benzaken S, Bernard G, Nachman P, Esnault V, Seitz-Polski B. Boyer-Suavet S, et al. Among authors: esnault v. Nephrol Dial Transplant. 2019 Aug 1;34(8):1423-1425. doi: 10.1093/ndt/gfz041. Nephrol Dial Transplant. 2019. PMID: 30929012 No abstract available.
High-Dose Rituximab and Early Remission in PLA2R1-Related Membranous Nephropathy.
Seitz-Polski B, Dahan K, Debiec H, Rousseau A, Andreani M, Zaghrini C, Ticchioni M, Rosenthal A, Benzaken S, Bernard G, Lambeau G, Ronco P, Esnault VLM. Seitz-Polski B, et al. Clin J Am Soc Nephrol. 2019 Aug 7;14(8):1173-1182. doi: 10.2215/CJN.11791018. Epub 2019 Jul 24. Clin J Am Soc Nephrol. 2019. PMID: 31340979 Free PMC article. Clinical Trial.
152 results